Details for: VOLUVEN
Company: FRESENIUS KABI CANADA LTD
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02278057 | VOLUVEN | HYDROXYETHYL STARCH 130/0.4 | 6 % | SOLUTION | INTRAVENOUS |
Summary Reports
Summary Safety Review - Hydroxyethyl Starch Solutions - Risk of Kidney Injury and Death
Summary Safety Review - Hydroxyethyl starch (voluven and volulyte) - Assessing the Potential Risk of Acute Kidney Injury in Non-Critically Ill Patients
Summary Safety Review - Hydroxyethyl starch (voluven and volulyte) - Assessing the Potential Risk of Acute Kidney Injury in Non-Critically Ill Patients
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.